Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01337063 · ClinicalTrials.gov registry record · NA
Multi-Center Medication Reconciliation Quality Improvement Study
A NA study of Adverse Drug Events and Medication Administered in Error, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 1,836
- Enrollment target
- 6
- Study locations
NCT01337063 is a NA study of Adverse Drug Events and Medication Administered in Error that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 1,836 participants, above the 483-participant average among 6 other Adverse Drug Events trials with a reported enrollment target (280% higher). The trial reports 6 study locations across 6 states.
The verdict
NCT01337063, a NA study of Adverse Drug Events and Medication Administered in Error, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,836 participants
- Enrollment target
- 6
- Study locations
Study Summary
Patients often have problems after they leave the hospital, in part because errors are made in the medications they are prescribed. The goal of this project is to develop a more accurate and safe medication prescription process when patients enter and leave the hospital and implement this process at six U.S. hospitals. The investigators will measure the success of the project and develop lessons learned so this process can be applied to other hospitals.
Conditions Studied
Interventions
- OTHER Mentored medication reconciliation quality improvement
Study Locations (6)
California
- University of California, San Francisco - San Francisco
Georgia
- Emory Johns Creek Hospital - Johns Creek
Illinois
- University of Chicago Hospitals and Clinics - Chicago
Massachusetts
- Baystate Health - Springfield
North Carolina
- Presbyterian Hospital - Charlotte
South Dakota
- Sioux Falls VA Medical Center - Sioux Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,836 participants |
| Start Date | 2011-03 |
| Est. Completion | 2014-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01337063
The ClinicalTrials.gov registry entry for NCT01337063 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,836 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 483-participant average among 6 other Adverse Drug Events trials with a reported enrollment target (280% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Adverse Drug Events appearing as the primary indexed condition, and to 1 intervention - of which Mentored medication reconciliation quality improvement is the first listed.
NCT01337063 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Georgia, Illinois.
Frequently Asked Questions
What is clinical trial NCT01337063 about?
NCT01337063 is a clinical study titled "Multi-Center Medication Reconciliation Quality Improvement Study". Patients often have problems after they leave the hospital, in part because errors are made in the medications they are prescribed. The goal of this project is to develop a more accurate and safe medication prescription process when patients enter and leave the hospital and implement this process at...
What is the current status of trial NCT01337063?
This trial is currently completed. It is a NA study. The enrollment target is 1,836 participants. The study started on 2011-03. Estimated completion is 2014-09.
What conditions does trial NCT01337063 study?
This clinical trial studies the following conditions: Adverse Drug Events, Medication Administered in Error.
What interventions are being tested in trial NCT01337063?
The interventions under investigation include: Mentored medication reconciliation quality improvement (OTHER).
Who is sponsoring clinical trial NCT01337063?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01337063 being conducted?
This trial has 6 study locations across California, Georgia, Illinois, Massachusetts, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adverse Drug Events
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Geriatric Emergency Department Pharmacologic Harm Prevention Project
RECRUITING · NA
-
Patient Profiling and Provider Feedback to Reduce Adverse Drug Events
COMPLETED · NA
-
The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial
COMPLETED · NA
-
Enhancing the Detection and Management of Adverse Drug Events in Nursing Homes
COMPLETED · NA
-
Improving Safety by Basic Computerizing Outpatient Prescribing
COMPLETED · Phase 2
-
Response to Medication Registry
COMPLETED
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.